Psychedelic research shows no sign of slowing down as researchers carried over the New Year’s momentum into February. Over the last month, we saw that psilocybin-assisted therapy’s effects on depression could last for up to 12 months. MDMA-assisted therapy led to reductions in alcohol use in patients with PTSD. At the same time, the first study assessing the effects of MDMA on fear extinction…

Source

Previous articlePsychedelic Bulletin: The Cost-Effectiveness of MDMA for PTSD; The Challenges Ahead for Psychedelic Medicine
Next articlePT299 – Ed Prideaux – HPPD (Hallucinogen Persisting Perception Disorder): A Synopsis